MedTrace Logo

Genetic Analysis for Predicting of Relapse During Steroid Treatment for Autoimmune Pancreatitis (AIP)

NCT00444444 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2007-06-26

No results posted yet for this study

Summary

To determine whether certain alleles or haplotypes of major histocompatibility complex gene are associated with AIP in Korean population, we undertook this study with high-resolution typing for HLA (sequence-based typing).

Primary outcomes: detection of novel allele associated with AIP in Korean population Secondary outcomes: detection of genetic factor for relapse of AIP during steroid treatment

Conditions

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Do Hyun Park, MD, PhD · Soon Chun Hyang University

  • Myung-Hwan Kim, MD, PhD · Asan Medical Center

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-02-28
Completion
2007-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00444444 on ClinicalTrials.gov